Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Open accessThe DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Significance: The failure in achieving a durable clinical immune response against cancer cells depends on the ability of cancer cells to establish a microenvironment that prevent cytotoxic immune cells to infiltrate tumors and kill cancer cells. Therefore, the key approach to achieving successful antitumor immune response is to harness strategies allowing the reorientation of immune cells to the tumor. Herein we reveal that inhibiting autophagy induces a massive infiltration of natural killer immune cells into the tumor bed, and a subsequent dramatic decrease in the tumor volume of melanomas. These results highlight the role of targeting autophagy in breaking the immunosuppressive tumor microenvironment barrier, thus allowing the infiltration of natural killer cells into the tumor to kill cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of autophagy (i.e., by shRNA silencing Becn1) induces a massive CCL5‐dependent infiltration of NK cells into melanoma tumors, thereby reducing tumor volume (Mgrditchian et al, 2017).”
From Autophagy in major human diseases (2021) · cites this paper as Mgrditchian et al, 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894 · cited 1×
“Autophagy involves a BECN1/class III phosphoinositide-3-kinase (PI3K) complex to initiate the formation of an isolation membrane, called the phagophore (20).”
BackgroundDérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Mammalian autophagy: core molecular machinery and signaling regulation
Yang, Z., & Klionsky, D. J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.014 · Cited by 1,956 · cited 1×
“Such a degradation process provides nutrients to maintain cellular functions under environmental stresses, thus allowing survival of cancer cells under stress conditions (18, 19).”
BackgroundHibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702 · cited 1×
“However, tumor cells often compromise the antitumor immunity by inducing an immunosuppressive microenvironment (59).”
BackgroundSelective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379 · cited 7×
“CCL5 interacts with different receptors including C-C chemokine receptor types 1, 3, and 5 (CCR1, CCR3, and CCR5) (42).”
BackgroundInfluentialThe Chemokine Superfamily Revisited
Zlotnik, A., & Yoshie, O. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.008 · Cited by 1,235 · cited 1×
“CCL5, also known as RANTES, is a small protein that belongs to a large family of cytokines and displays chemotaxis activity, as it is involved in inducing the migration of several leukocytes into inflammation sites (39).”
BackgroundThe Role of Autophagy in Cancer: Therapeutic Implications
Yang, Z. J., Chee, C. E., Huang, S., & Sinicrope, F. A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0047 · Cited by 1,215 · cited 1×
“A growing body of evidence suggests that autophagy could operate in tumor cells as an immunosuppressive and cellresistance mechanism, because autophagy blockade not only sensitizes tumor to chemotherapy (22) but also improves the antitumor immune response (23, 24).”
BackgroundChemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2281 · Cited by 1,121 · cited 2×
“While some reports highlight the role of CCL5 in promoting breast cancer metastasis (43), others refer the importance of CCL5 in T cell recruitment into melanomas (26).”
BackgroundTargeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,066 · cited 1×
“While the role of NK cells in tumor immune surveillance is well established and experimentally supported (2), the use of NK cells is far from being successfully and fully used in the clinic, although efforts are now being undertaken to exploit their antitumor properties (3).”
BackgroundCoca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., & Moreno, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · Cited by 716 · cited 2×
“Indeed, the long-lasting observations showing that NK cells are infrequently detected in tumor biopsies suggest that intratumoral NK cells can be associated with increased survival of cancer patients (7).”
BackgroundNK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs
Anaya, J. (2016) · PeerJ Computer Science · doi:10.7717/peerj-cs.67 · Cited by 639
Autophagy in Human Health and Disease
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1303158 · Cited by 615 · cited 1×
“ATG5, another autophagy-related protein, plays a role in the elongation of the phagophore and in its subsequent maturation into the complete autophagosome (21).”
BackgroundPrognostic value of intratumoral natural killer cells in gastric carcinoma
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S., & Aikou, T. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<577::aid-cncr13>3.0.co;2-v · Cited by 586 · cited 1×
“It is now well established that tumor infiltration by NK cells represents a positive prognostic marker in different cancers, including colorectal (7), gastric (52), and lung carcinomas (53).”
BackgroundRole of chemokines in the biology of natural killer cells
Robertson, M. J. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.2.173 · Cited by 516 · cited 5×
“Based on the fact that CXCL10 has also been described to induce the migration of NK cells (27), the involvement of CXCL10 in the homing of NK cells cannot be ruled out, and additional experiments need to be conducted to determine the relative contribution of CXCL10.”
BackgroundInfluentialFos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro.
Rauscher, F. J., Voulalas, P. J., Franza, B. R., & Curran, T. (1988) · Genes & Development · doi:10.1101/gad.2.12b.1687 · Cited by 507 · cited 1×
“We next investigated the expression and the activation of c-Jun, the AP-1 founding member (32).”
BackgroundNatural killer cell deficiency
Orange, J. S. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.020 · Cited by 504 · cited 1×
“In human and animal models, NK cell deficiency leads to increased incidence of different types of tumors (1).”
BackgroundHalama, N., Zoernig, I., Berthel, A., Kahlert, C., Klupp, F., Suarez-Carmona, M., Suetterlin, T., Brand, K., Krauss, J., Lasitschka, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.005 · Cited by 495 · cited 1×
“Furthermore, it should be noted that the CCL5 staining detected in melanoma biopsies may not be only produced by tumor cells, since other cells in the tumor microenvironment— such as T cells—can also secrete CCL5, as previously reported (56, 57).”
ResultChow, M. T., & Luster, A. D. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0160 · Cited by 485
Villegas, F. R., Coca, S., Villarrubia, V. G., Jiménez, R., Chillón, M. J., Jareño, J., Zuil, M., & Callol, L. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00292-6 · Cited by 467 · cited 1×
“It is now well established that tumor infiltration by NK cells represents a positive prognostic marker in different cancers, including colorectal (7), gastric (52), and lung carcinomas (53).”
BackgroundReduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases
Musti, A. M., Treier, M., & Bohmann, D. (1997) · Science · doi:10.1126/science.275.5298.400 · Cited by 462 · cited 1×
“Such phosphorylation serves to increase both its stability and transcriptional activity, as previously reported (50, 51).”
Alpha and β chemokines induce NK cell migration and enhance NK-mediated cytolysis
Taub, D. D., Sayers, T. J., Carter, C. R., & Ortaldo, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3877 · Cited by 449
Melero, I., Rouzaut, A., Motz, G. T., & Coukos, G. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0985 · Cited by 435 · cited 1×
“Therefore, strategies aiming at increasing the infiltration of NK cells into tumors would be of great interest to improve NK-based tumor immunotherapies (8).”
BackgroundThe Role of Chemokines in Melanoma Tumor Growth and Metastasis
Payne, A. S., & Cornelius, L. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01725.x · Cited by 361 · cited 2×
“and progression, including CXCL1, CXCL2, CXCL3, CXCL8, CCL2, and CCL5 (14).”
InfluentialBaginska, J., Viry, E., Berchem, G., Poli, A., Noman, M. Z., van Moer, K., Medves, S., Zimmer, J., Oudin, A., Niclou, S. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304790110 · Cited by 344 · cited 4×
“Consistent with the degradation property of autophagy, we have demonstrated that targeting BECN1 prevented the degradation of NK-derived GranzymeB (GzmB) in hypoxic melanoma cells, and therefore restored their susceptibility to NK cell-mediated killing (17).”
BackgroundInfluentialSelf-citationBeclin1: A role in membrane dynamics and beyond
Wirawan, E., Lippens, S., Vanden Berghe, T., Romagnoli, A., Fimia, G. M., Piacentini, M., & Vandenabeele, P. (2012) · Autophagy · doi:10.4161/auto.8.1.16645 · Cited by 293 · cited 1×
“A growing body of evidence has revealed that, in addition to its role in autophagy, BECN1 has several nonautophagic functions (28).”
BackgroundActivation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release
Loetscher, P., Seitz, M., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.322 · Cited by 282
Genomic organization and transcriptional regulation of the RANTES chemokine gene.
Nelson, P. J., Kim, H. T., Manning, W. C., Goralski, T. J., & Krensky, A. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2601 · Cited by 265 · cited 1×
“Indeed, the promoter region of mouse and human CCL5 contains several binding sites for well-defined transcription factors (29), including AP-1.”
BackgroundLim, J. Y. H., Gerber, S. A., Murphy, S. P., & Lord, E. M. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1506-7 · Cited by 257 · cited 1×
“Therefore, a positive correlation between the expression of some cytokines and the clinical outcome has been proposed (16).”
BackgroundNoman, M. Z., Janji, B., Kaminska, B., Van Moer, K., Pierson, S., Przanowski, P., Buart, S., Berchem, G., Romero, P., Mami-Chouaib, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1094 · Cited by 256 · cited 1×
“A growing body of evidence suggests that autophagy could operate in tumor cells as an immunosuppressive and cellresistance mechanism, because autophagy blockade not only sensitizes tumor to chemotherapy (22) but also improves the antitumor immune response (23, 24).”
BackgroundSelf-citationHong, M., Puaux, A.-L., Huang, C., Loumagne, L., Tow, C., Mackay, C., Kato, M., Prévost-Blondel, A., Avril, M.-F., Nardin, A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1466 · Cited by 246 · cited 1×
“In contrast, it has been shown that chemotherapy can also induce the expression of cytokines, including CCL5, involved in the trafficking of T cells into the tumor bed (15).”
BackgroundCCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
Svensson, S., Abrahamsson, A., Rodriguez, G. V., Olsson, A.-K., Jensen, L., Cao, Y., & Dabrosin, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0204 · Cited by 221 · cited 1×
“As tumoral CCL5 has been described to recruit T cells (54) and macrophages (55) into the tumor bed as well, we cannot exclude that melanoma tumors expressing a high level of CCL5 are not only highly infiltrated by NK cells but also by T cells and macrophages.”
BackgroundRole of Chemokines in the Biology of Natural Killer Cells
Maghazachi, A. A. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_20 · Cited by 216
Long, H., Xie, R., Xiang, T., Zhao, Z., Lin, S., Liang, Z., Chen, Z., & Zhu, B. (2012) · STEM CELLS · doi:10.1002/stem.1194 · Cited by 202 · cited 1×
“This implies that the autocrine CCL5 signaling, previously described to promote the invasion and migration of tumor cells (49), is attenuated in BECN1 tumor cells, and that CCL5 released by tumor cells primarily acts via paracrine signaling to attract NKs to the tumor bed.”
BackgroundFractalkine-Mediated Endothelial Cell Injury by NK Cells
Yoneda, O., Imai, T., Goda, S., Inoue, H., Yamauchi, A., Okazaki, T., Imai, H., Yoshie, O., Bloom, E. T., Domae, N., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4055 · Cited by 192
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
Ardolino, M., Azimi, C. S., Iannello, A., Trevino, T. N., Horan, L., Zhang, L., Deng, W., Ring, A. M., Fischer, S., Garcia, K. C., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74337 · Cited by 191 · cited 1×
“Since NK cell-infiltrating tumors could be functionally impaired/ exhausted (25), we then assessed the functional properties of the NK cells that infiltrated BECN1 tumors.”
BackgroundDahlberg, C. I. M., Sarhan, D., Chrobok, M., Duru, A. D., & Alici, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00605 · Cited by 184 · cited 1×
“It is now well accepted that NK cells are capable of driving potent antitumor responses (58).”
BackgroundStojanovic, A., Fiegler, N., Brunner-Weinzierl, M., & Cerwenka, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302091 · Cited by 175 · cited 1×
“Accumulating new evidence highlights that, similar to CTLs, activated NK cells can express, under some circumstances, the immune checkpoint programmed cell death protein 1- (PD-1) (9–11) and CTL-associated antigen 4 (CTLA4) (12).”
BackgroundAutophagy in Protein and Organelle Turnover
Mizushima, N. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011023 · Cited by 166 · cited 1×
“Such a degradation process provides nutrients to maintain cellular functions under environmental stresses, thus allowing survival of cancer cells under stress conditions (18, 19).”
BackgroundCC chemokines induce the generation of killer cells from CD56+ cells
Maghazachi, A. A., Al‐Aoukaty, A., & Schall, T. J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260207 · Cited by 163 · cited 1×
“It has been previously reported that CCL5 can increase the cytotoxicity of CD56 human NK cells (44).”
BackgroundZumwalt, T. J., Arnold, M., Goel, A., & Boland, C. R. (2015) · Oncotarget · doi:10.18632/oncotarget.3205 · Cited by 151 · cited 1×
“Furthermore, it should be noted that the CCL5 staining detected in melanoma biopsies may not be only produced by tumor cells, since other cells in the tumor microenvironment— such as T cells—can also secrete CCL5, as previously reported (56, 57).”
ResultThe Serine/Threonine Phosphatase, PP2A: Endogenous Regulator of Inflammatory Cell Signaling
Shanley, T. P., Vasi, N., Denenberg, A., & Wong, H. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.966 · Cited by 147 · cited 1×
“The serine/threonine phosphatase, PP2A, has been described to be involved in the regulation of JNK phosphorylation and subsequently in that of its downstream protein c-Jun (36).”
BackgroundDistinct but Overlapping Epitopes for the Interaction of a CC-Chemokine with CCR1, CCR3, and CCR5
Pakianathan, D. R., Kuta, E. G., Artis, D. R., Skelton, N. J., & Hébert, C. A. (1997) · Biochemistry · doi:10.1021/bi970593z · Cited by 143 · cited 7×
“CCL5 interacts with different receptors including C-C chemokine receptor types 1, 3, and 5 (CCR1, CCR3, and CCR5) (42).”
BackgroundInfluentialAlvarez, I. B., Pasquinelli, V., Jurado, J. O., Abbate, E. H., Musella, R. M., de la Barrera, S., & García, V. (2010) · The Journal of Infectious Diseases · doi:10.1086/654932 · Cited by 132
PD-1 Expression on Natural Killer Cells and CD8 + T Cells During Chronic HIV-1 Infection
Norris, S., Coleman, A., Kuri-Cervantes, L., Bower, M., Nelson, M. R., & Goodier, M. R. (2012) · Viral Immunology · doi:10.1089/vim.2011.0096 · Cited by 130
Liu, J., Li, F., Ping, Y., Wang, L., Chen, X., Wang, D., Cao, L., Zhao, S., Li, B., Kalinski, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4617 · Cited by 118 · cited 1×
“As tumoral CCL5 has been described to recruit T cells (54) and macrophages (55) into the tumor bed as well, we cannot exclude that melanoma tumors expressing a high level of CCL5 are not only highly infiltrated by NK cells but also by T cells and macrophages.”
BackgroundThe potential to target CCL5/CCR5 in breast cancer
Velasco-Velázquez, M., Xolalpa, W., & Pestell, R. G. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.949238 · Cited by 107 · cited 1×
“While some reports highlight the role of CCL5 in promoting breast cancer metastasis (43), others refer the importance of CCL5 in T cell recruitment into melanomas (26).”
BackgroundSmeal, T., Hibi, M., & Karin, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06946.x · Cited by 91
Hassan, S. S., Akram, M., King, E. C., Dockrell, H. M., & Cliff, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137646 · Cited by 72
Melanoma Cells Inhibit NK Cell Functions—Letter
Sconocchia, G., Arriga, R., Tornillo, L., Terracciano, L., Ferrone, S., & Spagnoli, G. C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1181 · Cited by 70 · cited 1×
“This might be in part related to the lack of crucial knowledge about NK cell-homing capacities (4, 5) and their poor infiltration into solid tumors (6).”
BackgroundSelvaraj, S., Kono, H., & Sarai, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00846-x · Cited by 68 · cited 1×
“We performed in silico identification of consensus (5′-TGA[C/G]TCA-3′) (30) and nonconsensus (5′TGACTgA-3′ or 5′-TGACTCc-3′) (31) motifs for the Jun/Fos Fig.”
MethodHypoxia-induced autophagy: A new player in cancer immunotherapy?
Noman, M. Z., Janji, B., Berchem, G., Mami-Chouaib, F., & Chouaib, S. (2012) · Autophagy · doi:10.4161/auto.19572 · Cited by 63
Self-citationImproving natural killer cell cancer immunotherapy
Berrien-Elliott, M. M., Romee, R., & Fehniger, T. A. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000243 · Cited by 53 · cited 1×
“Discussion The role of NK cells in the improvement of immune responses to cancer has been extensively investigated during the past few decades, and several NK cell-based immunotherapies have been proposed and are used in the clinic (38).”
BackgroundCell-Autonomous CCL5 Transcription by Memory CD8 T Cells Is Regulated by IL-4
Marçais, A., Coupet, C., Walzer, T., Tomkowiak, M., Ghittoni, R., & Marvel, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4451 · Cited by 33 · cited 1×
“CCL5 is secreted by a wide variety of cells, including T cells (40), NKs (27), and some tumor cells (41).”
BackgroundCytotoxic effects of crystal proteins from Bacillus thuringiensis against breast cancer cells.
Tharakan, B., Devaki, G., Nair, H., & Padikkala, J. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-3077 · Cited by 26
Soria, G., Lebel-Haziv, Y., Ehrlich, M., Meshel, T., Suez, A., Avezov, E., Rozenberg, P., & Ben‐Baruch, A. (2012) · Neoplasia · doi:10.1593/neo.111122 · Cited by 24
c-Jun binding site identification in K562 cells
Li, M., Ge, Q., Wang, W., Wang, J., & Lu, Z. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.05.004 · Cited by 19 · cited 1×
“We performed in silico identification of consensus (5′-TGA[C/G]TCA-3′) (30) and nonconsensus (5′TGACTgA-3′ or 5′-TGACTCc-3′) (31) motifs for the Jun/Fos Fig.”
MethodThe Pathophysiological Role of Chemokines in the Regulation of NK Cell Tissue Homing
Bernardini, G., & Santoni, A. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014010386 · Cited by 14 · cited 1×
“This might be in part related to the lack of crucial knowledge about NK cell-homing capacities (4, 5) and their poor infiltration into solid tumors (6).”
BackgroundHietakangas, V., Elo, I., Rosenström, H., Coffey, E. T., Kyriakis, J. M., Eriksson, J., & Sistonen, L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02810-1 · Cited by 12 · cited 1×
“c-Jun phosphorylation is mediated by the upstream kinase JNK, which in turn is exclusively phosphorylated by MKK4 kinase (35).”
BackgroundTang, F., Fu-yu, W., & Pai, M. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-5428 · Cited by 2
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Autophagy and autophagy-related pathways in cancer
Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,403
Targeting Autophagy in Cancer: Recent Advances and Future Directions
Amaravadi, R. K., Kimmelman, A. C., & Debnath, J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0292 · Cited by 928
Onorati, A. V., Dyczynski, M., Ojha, R., & Amaravadi, R. K. (2018) · Cancer · doi:10.1002/cncr.31335 · Cited by 837
“It was found that autophagy inhibition also enhances cell death from natural killer cells.(95) Within the same study, deletion of Beclin1 caused influx of immune cells into the tumor microenvironment.”
BackgroundAutophagy in tumour immunity and therapy
Xia, H., Green, D. R., & Zou, W. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00344-2 · Cited by 404
Metadata
- Authors
- Mgrditchian, T., Arakelian, T., Paggetti, J., Noman, M. Z., Viry, E., Moussay, E., Van Moer, K., Kreis, S., Guerin, C., Buart, S., Robert, C., Borg, C., Vielh, P., Chouaib, S., Berchem, G., & Janji, B.
- Affiliations
- Luxembourg Institute of Health (LU)
- Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, L-1526 Luxembourg City, Luxembourg;
- University of Luxembourg (LU)
- National Cytometry Platform, Department of Infection and Immunity, Luxembourg Institute of Health, L-4354 Esch-sur-Alzette, Luxembourg;
- INSERM UMR 1186, Gustave Roussy Cancer Center, 94805-Villejuif, France;
- Inserm (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Laboratoire National de Santé (LU)
- Centre Hospitalier de Luxembourg (LU)
- Corresponding author
- Janji, Bassam
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-10-16
- Volume
- 114
- Issue
- 44
- Pages
- E9271-E9279
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5676879
- OpenAlex
- W2766463091
- Cited by
- 226
- References
- 63
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 23 · 2023: 33 · 2022: 28 · 2021: 38 · 2020: 33 · 2019: 26 · 2018: 13
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, other-oa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Funders
- Fonds National de la Recherche Luxembourg (AFR 7842786)
- Fonds De La Recherche Scientifique - FNRS (7.6503)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- autophagy inhibition, melanoma, natural killer cells, NK cell infiltration, RANTES, tumor microenvironment, immunosuppression, antitumor immunity, tumor growth
- MeSH terms
- Beclin-1, Animals, Autophagy, Humans, Immunotherapy, Killer Cells, Natural, Melanoma, Mice, Inbred C57BL, Chemokine CCL5, Cell Line, Tumor, Mice, Natural Cytotoxicity Triggering Receptor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.